Literature DB >> 24479831

Serum concentrations of cytokines in infants with retinopathy of prematurity.

Honghua Yu1, Ling Yuan, Yuping Zou, Lianghong Peng, Yong Wang, Tao Li, Shibo Tang.   

Abstract

Retinopathy of prematurity (ROP) is the leading cause of blindness in preterm infants. In this study, we investigated the cytokine levels in cord blood of normal preterm neonates and preterm infants developed ROP. Serum levels of 10 cytokines in umbilical cord blood were measured by multiplex protein arrays from 62 healthy preterm neonates and 30 preterm neonate cases who developed ROP at later stage. Results showed that serum levels of cytokines including interleukin 7 (IL-7), monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), and macrophage inflammatory protein 1 beta (MIP-1β) were significantly increased in cases who developed ROP than in healthy preterm neonates (3.5-fold, 3.2-fold, 3.4-fold, and 2.1-fold, respectively), whereas levels of these four cytokines did not reveal any significant differences between healthy preterm infants and normal infants. When comparing the expression of cytokines in ROP patients with different clinical parameters, ROP cases whose gestational age at delivery earlier than 29.0 weeks demonstrated increased levels of MCP-1 and MIP-1β than those later than 29.0 weeks (p < 0.05). Also, ROP cases with birth weight less than 1.28 kg revealed significantly higher level of MIP-1β than those who were heavier than 1.28 kg (p < 0.05). These data indicated that levels of IL-7, MCP-1, MIP-1α, and MIP-1β were associated with increased risk of ROP, in which MIP-1β may be further correlated with the severity of ROP.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cytokine; retinopathy of prematurity

Mesh:

Substances:

Year:  2014        PMID: 24479831     DOI: 10.1111/apm.12223

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  14 in total

1.  Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab.

Authors:  Jiao Lyu; Qi Zhang; Haiying Jin; Yu Xu; Chunli Chen; Xunda Ji; Xiang Zhang; Yuqing Rao; Peiquan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-09       Impact factor: 3.117

Review 2.  Diverse roles of macrophages in intraocular neovascular diseases: a review.

Authors:  Ye-Di Zhou; Shigeo Yoshida; Ying-Qian Peng; Yoshiyuki Kobayashi; Lu-Si Zhang; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

Review 3.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 4.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

5.  Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death.

Authors:  Jegen Kandasamy; Claire Roane; Alexander Szalai; Namasivayam Ambalavanan
Journal:  Pediatr Res       Date:  2015-08-13       Impact factor: 3.756

Review 6.  Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Authors:  José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob
Journal:  J Neuroinflammation       Date:  2017-08-22       Impact factor: 8.322

7.  Abnormal Complement Activation and Inflammation in the Pathogenesis of Retinopathy of Prematurity.

Authors:  Sonika Rathi; Subhadra Jalali; Satish Patnaik; Shahna Shahulhameed; Ganeswara R Musada; Divya Balakrishnan; Padmaja K Rani; Ramesh Kekunnaya; Preeti Patil Chhablani; Sarpras Swain; Lopamudra Giri; Subhabrata Chakrabarti; Inderjeet Kaur
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

8.  Ureaplasma isolates stimulate pro-inflammatory CC chemokines and matrix metalloproteinase-9 in neonatal and adult monocytes.

Authors:  Kirsten Glaser; Christine Silwedel; Markus Fehrholz; Birgit Henrich; Ana Maria Waaga-Gasser; Heike Claus; Christian P Speer
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

9.  Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity.

Authors:  Yong Cheng; Xuemei Zhu; Dandan Linghu; Yongsheng Xu; Jianhong Liang
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

Review 10.  Ischemic Retinopathies: Oxidative Stress and Inflammation.

Authors:  José Carlos Rivera; Rabah Dabouz; Baraa Noueihed; Samy Omri; Houda Tahiri; Sylvain Chemtob
Journal:  Oxid Med Cell Longev       Date:  2017-12-19       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.